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responsibility of XAbstract A simple and sensitive kinetic spectrophotometric method has been developed and
validated for determination of amlodipine besylate (AML). The method was based on the
condensation reaction of AML with 7-chloro-4-nitro-2,1,3-benzoxadiazole in an alkaline buffer
(pH 8.6) producing a highly colored product. The color development was monitored spectro-
phometrically at the maximum absorption lmax 470 nm. The factors affecting the reaction were
studied and the conditions were optimized. The stoichiometry of the reaction was determined, and
the reaction pathway was postulated. Moreover, both the activation energy and the speciﬁc rate
constant (at 70 1C) of the reaction were found to be 6.74 kcal mole1 and 3.58 s1, respectively. The
initial rate and ﬁxed time methods were utilized for constructing the calibration graphs for the
determination of AML concentration. Under the optimum reaction conditions, the limits of
detection and quantiﬁcation were 0.35 and 1.05 mg/mL, respectively. The precision of the method
was satisfactory; the relative standard deviations were 0.85–1.76%. The proposed method was
successfully applied to the analysis of AML in its pure form and tablets with good accuracy; the
recovery percentages ranged from 99.5571.69% to 100.6571.48%. The results were compared
with that of the reported method.
& 2012 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.ersity. Production and hosting by E
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i’an Jiaotong University.1. Introduction
Amlodipine besylate (AML), (4R, S)-3-ethyl-5-methyl 2-(2-
amino-ethoxy-methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl
pyridine-3,5-dicarboxylate monobenzene sulphonate, is a
potent long-acting calcium channel blocking agent [1]. It is
widely used for the treatment of hypertension as well as the
stable and variant angina [2]. It is more effective than b-
blockers in the treatment of variant angina because it prevents
and reverses the coronary spasms resulting in increased bloodlsevier B.V. All rights reserved.
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selectively the arterial vascular smooth muscle cell prolifera-
tion resulting in prevention of the progressive narrowing of the
arteries [4,5]. Amilodipine is ofﬁcial in BP, USP and
EUP [6–8].
Because of the therapeutic importance of AML, many
methods have been developed for its determination in phar-
maceutical dosage forms and/or biological ﬂuids. These
methods include high performance liquid chromatography
(HPLC) [6–13], high performance thin layer chromatography
(HPTLC) [14,15], gas chromatography (GC) [16,17], capillary
electrophoresis [18], ﬂow injection analysis [19], differential-
pulse square-wave anodic voltammetry [20], and enzyme
immunoassay [21]. Spectrophotometry because of its inherent
simplicity is considered one of the most convenient alternative
techniques. Few spectrophotometric methods have been
reported for the determination of AML [22–32]. However,
some of these methods are expensive, somewhat time consum-
ing and require sophisticated instruments that may be una-
vailable in many quality control laboratories. In comparison
with HPLC technique the developed method is simple, cost
effective and it is sensitive than other reported methods as
HPLC [9], HPTLC [15] and more selective and sensitive than
reported spectrophotometric method which its linear range is
5.0–30.0 mg/mL [22]. Therefore, the development of more
simple, rapid, selective and sensitive method for the determi-
nation of AML is necessary. Kinetic spectrophotometric
methods are becoming of great interest in pharmaceutical
analysis [33]. Application of the kinetic methods offered some
advantages such as improved selectivity, avoiding the inter-
ference of the colored and/or turbidity background of the
samples, and possible avoiding of the interference of the other
active compounds present in the commercial product if they
are resisting the reaction conditions established for the
proposed kinetic method. No attempts have yet been made
to develop kinetic spectrophotometric method for determina-
tion of AML. For these reasons, the aim of the present study
was directed to the development of kinetic spectrophotometric
method for the determination of AML in tablets using
7-chloro-4-nitro-2,1,3-benzoxadiazole (NBD-Cl) reagent which
is selective for primary and secondary amines. The method was
based on the condensation reaction of AML with (NBD-Cl)
in an alkaline buffered medium producing a highly colored
product exhibiting maximum absorption peak at 470 nm. The
rate of color development was monitored spectrophometrically,
and employed in the development of the proposed method.2. Experimental
2.1. Apparatus
UV-1601 PC, Ultraviolet–visible spectrophotometer (Shi-
madzu, Japan), with 1-cm matched quartz cells, was used for
all measurements. Super-mixer (Lab-line Instruments, Inc.,
USA). MLW type thermostatically controlled water bath
(Memmert GmbH, Co. Schwa bach, Germany).
2.2. Chemicals and tablets
Amlodipine besylate (AML; Hetero Drugs Ltd., Hyderabad,
India), was used as received (the purity was 99.2–100.2%).NBD-Cl (Merck, Darmstadt, Germany) was 0.08% (w/v) in
methanol and it was freshly prepared daily. The following
available tablets were used in the present investigation: Regcor
tablets (Egyptian International Pharmaceutical Industries Co.,
Cairo, Egypt) and Alkapress tablets (Alkan Pharma, Cairo,
Egypt) are labeled to contain 5 mg of AML per tablet. All
solvents and other chemicals used throughout this study were of
analytical grade. Water was doubly distilled.
2.3. Preparation of solutions
2.3.1. Stock standard solution
An accurately weighed amount (25 mg) of amlodipine besylate
was dissolved in 10 mL methanol in a 50-mL volumetric ﬂask.
The solution was then diluted to the mark with methanol to
obtain a working standard solution of 0.5 mg/mL of AML.
The solution was found to be stable for at least one weak when
kept in the refrigerator.
2.3.2. Tablets sample solutions
Twenty tablets of each formulation were weighed and ﬁnely
powdered. A quantity of the mixed powder equivalent to 25 mg
of the active component was transferred to a 50-mL calibrated
ﬂask, dissolved in 25 mL methanol, swirled and sonicated for
5 min, completed to volume with methanol, shaken well for
10 min, and ﬁltered. The procedure was completed as described
for preparation of stock standard solution.
2.3.3. Buffer solution
Teorell and Stenhagen buffer solution [34] at pH 8.6 was prepared
in freshly boiled and cooled distilled water. The buffer was com-
posed of phosphoric acid, citric acid, and 1M sodium hydroxide,
adjusted to the required pH with 0.1 M hydrochloric acid.
2.4. General analytical procedures
One milliliter of the standard or sample solution (20–1000 mg/
mL) was transferred to test tube, then 1 mL of Torell and
Stenhagen buffer solution (pH 8.6) and 1 mL of NBD-Cl
reagent (0.08%, w/v in methanol) were added, respectively.
The reaction was allowed to proceed at 70 1C in a water bath
for the speciﬁc time. Then, the test tubes were cooled in ice bath
and 0.2 mL of concentrated sulphuric acid was added and
mixed well. The contents were quantitatively transferred to 10-
mL calibrated ﬂasks and diluted to the mark with methanol.
The absorbance of the resulting solutions was measured or
monitored at 470 nm against reagent blanks treated similarly.
2.5. Determination of the molar ratio of the reaction
The Job’s method of continuous variation [35] was employed.
Master equimolar solutions of AML and NBD-Cl reagent
were prepared. The concentrations of these solutions were
5 103 M in methanol. Series of 10-mL portions of the
master solutions of AML with the reagent were made up of
different complementary proportions (0:10, 1:9, yy, 9:1,
10:0, inclusive) in test tubes. Then, 1 mL of Torell and
Stenhagen buffer solution (pH 8.6) was added to each tube.
The reactions were allowed to proceed at 70 1C in a water bath
for 35 min. Then, the test tubes were cooled in ice bath and
0.2 mL of concentrated sulphuric acid was added and mixed
well. The contents were quantitatively transferred to 10.0-mL
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Fig. 1 Absorption spectrum of the reaction product of AML
(20 mg/mL) with NBD-Cl (0.08% w/v).
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A.M. Mahmoud et al.336calibrated ﬂasks and diluted to the mark with methanol. The
absorbance of the resulting solutions was measured at 470 nm
against reagent blanks treated similarly.
2.6. Activation energy of the kinetic reaction of AML with
NBD-Cl
The reaction time of AML with NBD-Cl was performed at
different temperatures; 25, 40, 60, 70, and 80 1C using 20 mg/
mL of AML and 1 mL of 0.08% (w/v) of NBD-Cl reagent at
pH 8.6. The absorption-time curves at these temperatures were
constructed to determine the initial rates, then plotting 1/T
against log k to determine the slope of the line (activation
energy of the reaction).
2.7. Data acquisition and processing
The kinetic data recorded for the proposed method were
transformed to the Slide Write Plus software, version 5.011
(Advanced Graphics Software, Inc., CA, USA) for curve
ﬁtting, regression analysis, and statistical calculations. The
initial rate (V) of the reaction at different concentrations was
obtained from the slope of the tangent to the absorbance-time
curve. The calibration curve was constructed by plotting the
logarithm of the initial rate (log V) of reaction versus loga-
rithm of the concentration (log C) of AML. Alternatively, the
calibration curve was constructed by plotting the absorbance
measured after a ﬁxed time of 30 min.
The limits of detection (LOD) and limits of quantitation
(LOQ) were determined [36] using the formula: LOD or
LOQ¼kSDa/b, where k¼3.3 for LOD and 10 for LOQ, SDa
is the standard deviation of the intercept, and b is the slope.Fig. 2 Effect of NBD-Cl concentration on its reaction with AML
(20 mg/mL).3. Results and discussion
3.1. Optimum conditions for the reaction of AML with NBD-
Cl
NBD-Cl is an activated halide derivative, which was ﬁrst
introduced as a ﬂuorigenic reagent for the determination of
some amines [30,34]. In further, it was used as a chromogenic
reagent for the colorimetric determination of many pharma-
ceutical amines: e.g. b-blokers [37] and H2-receptor antago-
nists [38]. In the present study, the reaction of AML with
NBD-Cl produced a highly colored product exhibiting max-
imum absorption peak at 470 nm (Fig. 1). It was found that
the formation of the colored product increased with time,
therefore it was deemed useful to elaborate a kinetically based
method for the determination of AML. The following para-
graphs describe the conditions under which the reaction of
AML with NBD-Cl fulﬁlls the requirements necessary for its
spectrophotometric analysis.
Owing to the presence of labile chloride in the chemical
structure of NBD-Cl, a daily fresh solution is recommended. The
effect of NBD-Cl concentration on the reaction was studied at
room temperature (2575 1C) and away from direct sun or
artiﬁcial daylight. As shown in Fig. 2, the reaction of AML
with NBD-Cl was dependent on the concentration of NBD-Cl
reagent. The highest absorbance intensity was attained when the
concentration of NBD-Cl reagent in the ﬁnal solution wasbetween 0.006 and 0.010% (w/v). Therefore, a concentration of
0.008% (w/v) (1 mL of 0.08% (w/v) working reagent solution)
was selected for further experiments.
To generate the nucleophile from AML, different buffers at
different pH values (7.0–10.0) were investigated. Best results
were obtained in the case of Teorell and Stenhagen buffer at pH
8.6 (Fig. 3). At higher pH values, precipitation of white colloid
occurred upon addition of NBD-Cl, high blank readings, non
reproducible results, and/or weak sensitivity were observed.
The effect of temperature on the reaction time was studied
by performing the reaction at different temperatures (30, 40,
60, 70, 80, and 90 1C) and the results indicated that maximum
readings were obtained at 70 1C (Fig. 4). At higher tempera-
ture, dramatic decrease in the absorbance values was
observed. This was attributed probably to the instability of
AML-NBD product at high temperature. NBD-Cl is hydro-
lyzed in alkaline medium to give NBD-OH which has
absorption intensity at 470 nm. Therefore, it was necessary
to acidify the reaction mixture to pH 2.0 before carrying out
the measurements to decrease the absorbance of the reagent
blank [39]. In order to select the most appropriate acid for the
acidiﬁcation of the reaction mixture, different acids were
tested including sulphuric, hydrochloric, perchloric, nitric,
phosphoric and acetic acids. The results indicated that
sulphuric acid was the most suitable acid as it yielded the
6.6
pH
0.0
0.2
0.4
0.6
0.8
1.0
A
bs
or
ba
nc
e
7.6 8.6 9.6 10.6
Fig. 3 Effect of pH on the reaction of AML (20 mg/mL) with
NBD-Cl.
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Fig. 4 Effect of temperature on the reaction of AML (20 mg/mL)
with NBD-Cl.
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Fig. 5 Pathway for the reaction of AML with NBD-Cl.
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concentrated sulphuric acid was 0.2 mL.
In order to select the most appropriate solvent for dilution,
different solvents of varying polarities were carefully tested:
water, methanol, ethanol, acetonitrile, and acetone. Methanol
was found to be an ideal diluting solvent as it afforded
maximum absorption intensity, and therefore it was selected
for further investigations. A marked hypsochromic shift with
hypochromic effect was observed in the absorption spectrum
of the colored product with increasing solvent polarity. This
ﬁnding was in agreement with the fact that polar solvents
cause stabilization of the ground state of n-pn transition
peaks through a hydrogen bonding [40], and was also coin-
cident with previous results [41].3.2. Stoichiometry and reaction mechanisms
The stoichiometry of the reaction of AML with NBD-Cl was
determined by the Job’s method [35]. The ratio of AML:NBD-Cl
was found to be 1:1, although there are two amino groups available
for reacting with NBD-Cl reagent. Based on the differential higher
reactivity of the primary amino group than that of the secondary
one, the reaction between AML and NBD-Cl was proposed to
proceed according to the pathway given in Fig. 5.3.3. Kinetics of the reaction
Under the above described optimum conditions (Table 1), the
absorbance-time curves for the reactions of AML with NBD-Cl
were generated (Fig. 6). The initial rates of the reaction were
determined from the slopes tangents of the absorption-time
curves. The order of the reaction with respect to the analytical
reagent was determined by studying the reaction at different
concentrations of the reagent with ﬁxed concentration of AML.
The plot of the initial rate, dA/dt, against the initial absorbance
was linear passing through the origin, indicating that the initial
order of the reaction with respect to the analytical reagent was
one. The order with respect to AML was evaluated from the
measurement of the rates of the reaction at several concentrations
of AML at a ﬁxed concentration of the reagent, which were
found to be one. However under the optimized experimental
conditions, the concentration of AML was determined using
relative excess amount of NBD-Cl and the other conditional
reagents. Therefore, pseudo-ﬁrst order conditions were obtained
with respect to their concentrations
3.4. Activation energy of the reaction
The activation energy, the minimum kinetic energy that a
molecule must possess in order to undergo reaction, can be
determined from Arrhenius equation:
V ¼ k¼AeEa=RT
where V (k) is the reaction rate, A is a constant known as
frequency factor, Ea is the activation energy, T is the absolute
temperature, and R is the gas constant; 1.987 cal/degree mole.
The logarithmic form of the above equation is written as follow:
Logk¼ logA2Ea=2:303RT
The activation energy of the kinetic reaction of AML with
NBD-Cl was determined by studying the reaction at different
temperatures (25, 40, 60, 70, and 80 1C) using ﬁxed concen-
trations of AML and the reagent. The absorption-time curves
Table 1 Analytical parameters for the initial rate method of the proposed kinetic spectrophotometric method for determination
of AML.
Linear range (M) Least square equation (Log
V¼ log K0þn log C)a
Correlation coefﬁcient (r) LOD (M) LOQ (M)
Intercept (log K) Slope (n)
0.55 105–8.22 105 (5–30)b 2.3322 0.9628 0.9998 0.09 105 (0.35)b 0.27 105 (1.05)b
aV is the reaction rate, K0 is the conditional rate constant, n is the order of reaction, and C is the molar concentration of AML.
bFigures in parenthesis are the linear range in mg/mL.
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Fig. 6 Absorbance-time curves for the reaction of varying
concentrations of AML (0.55 105–8.22 105 M) with NBD-
Cl.
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rates, then plotting 1/T against log k to determine the slope of
the line; Ea/2.303R (Fig. 7). The activation energy was found
to be 6.74 kcal mole1. This low activation energy explained
that the nucleophilic substitution reaction between AML and
NBD-Cl could easily take place under mild conditions, and
NBD-Cl could be used as a useful reagent in the spectro-
photometric determination of AML.
3.5. Quantitation methods
3.5.1. Initial rate method
The initial rates of AML reaction with NBD-Cl would follow
a pseudo-ﬁrst order, and were found to obey the following
equation:
V ¼DA=Dt¼K 0Cn
where V is the reaction rate, A is the absorbance, t is the
measuring time, K0 is the pseudo-ﬁrst order rate constant, C is
the molar concentration of AML, and n is the order of the
reaction. The logarithmic form of the above equation is
written as follow:
LogV ¼ logDA=Dt¼ logK 0 þ n logC
Regression analysis using the method of least square was
performed to evaluate the slope, intercept and correlation
coefﬁcient. The analytical parameters and results of regression
analysis are given in Table 1. Speciﬁc rate constant of the
kinetic reaction of AML with NBD-Cl (k, at 70 1C) wasdetermined and found to be 214.88 min1 or 3.58 s1. The
value of n in the regression equation was 0.9623 (E1),
conﬁrming that the reaction of AML with NBD-Cl was ﬁrst
order with respect to the AML concentration. The limit of
detection (LOD) and limit of quantiﬁcation (LOQ) were found
to be 0.35 and 1.05 mg/mL, respectively. These low values
conﬁrmed the good sensitivity of the initial rate method and
consequently its capability to determine low amounts
of AML.
3.5.2. Fixed time method
In this method, the absorbance of the reaction solutions
containing varying amounts of AML was measured at a pre-
selected ﬁxed time. Calibration plots of absorbance versus the
concentrations of AML were established at ﬁxed periods of
time for the reaction (Table 2). The regression equations,
correlation coefﬁcients, and the LOD and LOQ are given in
Table 2. The lowest limits of detection and quantiﬁcation were
obtained with ﬁxed times of 25, 30, and 35 min. However, the
ﬁxed time of 5 min showed wider concentration range for
quantiﬁcation. According to the ICH guidelines for validation
of analytical procedures [42], the detection limit is not required
to be part of the validation. Therefore, on the basis of wider
concentration range and less time of analysis, the ﬁxed time of
5 min was recommended for the determination of AML.
3.5.3. Validation of the proposed methods
3.5.3.1. Accuracy and precision. The accuracy and precision
of the proposed kinetic spectrophotometric method were
Table 2 Analytical parameters for the ﬁxed-time method of the proposed kinetic spectrophotometric method for the
determination of AML.
Reaction time
(min)
Linear range (mg/
mL)
Correlation coefﬁcient
(r)
Slope
(b)
SDb Intercept
(a)
SDa LOD
(mg ml1)
LOQ
(mg ml1)
1 10.0–100.0 0.9995 0.0044 0.0001 0.0021 0.0014 1.06 3.21
5 5.0–75.0 0.9997 0.0067 0.0001 0.0001 0.0016 0.81 2.47
10 5.0–50.0 0.9986 0.0147 0.0004 0.0022 0.0031 0.69 2.09
15 4.0–45.0 0.9998 0.0202 0.0002 0.0025 0.0036 0.59 1.78
20 3.0–35.0 0.9999 0.0243 0.0001 0.0037 0.0030 0.40 1.22
25 3.0–35.0 0.9994 0.0267 0.0001 0.0034 0.0028 0.35 1.05
30 2.0–30.0 0.9993 0.0291 0.0002 0.0083 0.0032 0.36 1.08
35 2.0–30.0 0.9998 0.0314 0.0003 0.0176 0.0032 0.34 1.02
Table 3 Evaluation of the accuracy and precision of the
initial rate and ﬁxed time methods of the proposed kinetic
spectrophotometric method for determination of AML.
Amount taken (mg/
mL)
Recovery (%7RSD)a
Initial rate
method
Fixed time
method
5.0 100.471.76 99.771.13
15.0 99.571.22 100.670.85
30.0 101.171.04 100.971.42
aRecovery was calculated as the amount found/amount
taken  100. Values are mean7RSD for ﬁve determinations.
Table 4 Standard addition method for the determination
of AML by the initial rate and ﬁxed time methods of the
proposed kinetic spectrophotometric method.
Tablet Amount added
(mg/mL)
Recovery (%7RSD) a
Initial rate
method
Fixed time
method
Alkapress 20 99.271.33 98.671.11
Regcor 20 98.870.79 99.470.92
aMean7RSD for ﬁve determinations.
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analyzing ﬁve replicate samples of each concentration by
both the initial rate and ﬁxed time methods. The relative
standard deviations (RSD) for the results ranged from 1.04%
to 1.76% and 0.85% to 1.42% for the initial rate and ﬁxed
time methods of the proposed kinetic spectrophotometric
method, respectively (Table 3), proving the high reproduci-
bility of the results and the precision of the method. This
good level of precision was suitable for quality control
analysis of AML in its pharmaceutical tablets.3.5.4. Analytical recovery and interference liabilities
The accuracy of the proposed kinetic method was also tested by
carrying out the recovery experiments using the standard addition
method [43]. Known amounts of pure AML were added to the
pre-analyzed AML-containing tablets, and then determined by
the recommended kinetic procedures. The obtained recoveries
and relative standard deviations were in the range of 98.6–99.4%
and 0.79–1.33%, respectively (Table 4). These results prove the
accuracy of the proposed methods and absence of interferences
from the common excipients. It is worth noting that the proposed
kinetic spectrophotometric method was performed in the visible
region away from the UV-absorption region of the UV-absorbing
interfering excipient materials that might be co-extracted from the
AML-containing tablets.3.5.5. Robustness and ruggedness
Robustness was tested by evaluating the inﬂuence of small
variation in the experimental parameters on the analyticalperformance of the method [44]. In these experiments, one
parameter was changed while the others were kept constant,
and the recovery percentage was calculated each time. It was
found that none of these variables signiﬁcantly affected the
performance of the method; the recovery values were between
98.9071.46% and 101.3071.92%. This provides an indica-
tion of the reliability of the proposed method during the
routine application of the proposed method. Ruggedness was
also tested by applying the proposed method to the assay of
AML using the same operational conditions but using two
different instruments at two different laboratories and differ-
ent elapsed time. Results obtained from lab-to-lab and day-to-
day variations were reproducible, as the relative standard
deviations (RSD) did not exceed 2.32%.3.6. Application of the proposed methods
The initial rate and ﬁxed time methods of the proposed kinetic
spectrophotometric method for determining AML have been
performed on commercial pharmaceutical tablets. The con-
centration of AML was computed from its corresponding
regression equations. The results of the proposed methods
(initial rate or ﬁxed time) were statistically compared with
those of the reported method [27], in respect to the accuracy
and precision. The mean recovery values of the claimed
amounts were between 99.5571.69% and 100.6571.48%
(Table 5). The results of t- and F-tests indicated no signiﬁcant
differences between both the proposed and the reported
methods at 95% conﬁdence level. This indicated similar
precision and accuracy in the analysis of AML in tablets.
Table 5 Analysis of AML-containing tablets by the reported and the initial rate and ﬁxed time methods of the proposed kinetic
spectrophotometric method.
Tablet Label claim (%7RSD)a
Initial rate method Fixed time method Reported methodb
Alkapress 99.5571.69 (0.83, 2.07)c 100.0572.01 (0.43, 1.46) 100.6572.43
Regcor 99.8471.58 (1.52, 1.08) 100.6571.48 (0.68, 1.23) 101.3971.64
aValues are mean of ﬁve determinations.
bRef. [19].
cFigures in parenthesis are the calculated values of t and F at 95% conﬁdence limit, respectively. The tabulated t- and F-values are 2.78
and 6.39, respectively.
A.M. Mahmoud et al.3404. Conclusion
A simple and sensitive kinetic spectrophotometric method for
the determination of AML has been successfully developed
and validated. The method was based on the coupling reaction
of AML with NBD-Cl. The initial rate and ﬁxed time methods
for the proposed kinetic spectrophotometric method can be
easily applied to the determination of AML in its pure form
and tablets. Also, the activation energy of the proposed kinetic
reaction was determined. The proposed method is sensitive
enough to enable determination of lower amounts of the drug,
and compared with the previously reported methods in terms
of accuracy and precision. The proposed method, because it
involves measurements in the visible region, is more selective
than the reported spectrophotometric methods that involve
measurement in ultraviolet region. These advantages encou-
rage the application of the proposed methods in routine
analysis of AML in quality control laboratories, as alterna-
tives for the existing methods.References
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